As global markets respond to encouraging inflation data, Germany's DAX index has shown resilience, gaining 1.48% this past week. This positive momentum in the German market sets a favorable backdrop for examining growth-oriented companies with high insider ownership, which often signals strong confidence in the company's future from those who know it best. Top 10 Growth Companies With High Insider Ownership In Germany Name Insider Ownership Earnings Growth pferdewetten.de (XTRA:EMH) 26.8% 75.4% Deutsche Beteiligungs (XTRA:DBAN) 39.1% 31.6% YOC (XTRA:YOC) 24.8% 21.8% NAGA Group (XTRA:N4G) 14.1% 74.7% Exasol (XTRA:EXL) 25.3% 105.4% Alelion Energy Systems (DB:2FZ) 37.4% 106.6% Stratec (XTRA:SBS) 30.9% 21.9% elumeo (XTRA:ELB) 25.8% 99.1% Redcare Pharmacy (XTRA:RDC) 17.7% 47.4% Friedrich Vorwerk Group (XTRA:VH2) 18% 30.4% Click here to see the full list of 17 stocks from our Fast Growing German Companies With High Insider Ownership screener. Let's dive into some prime choices out of from the screener. Brockhaus Technologies Simply Wall St Growth Rating: ★★★★☆☆ Overview: Brockhaus Technologies AG operates as a private equity firm with a market capitalization of approximately €304.03 million. Operations: The firm's revenue is primarily generated from its Financial Technologies and Security Technologies segments, contributing €153.43 million and €39.43 million respectively. Insider Ownership: 26.6% Earnings Growth Forecast: 74.2% p.a. Brockhaus Technologies, a German growth company with high insider ownership, is set to become profitable within the next three years, outpacing average market growth. While its revenue growth of 17.8% per year is robust compared to the German market's 5.4%, it falls short of the 20% benchmark often associated with high-growth companies. The firm's recent earnings report showed a substantial increase in sales to €39.97 million from €33.89 million year-over-year, although it still posted a net loss of €1.38 million, indicating challenges in achieving profitability despite growing revenues and earnings projected to rise significantly at 74.21% annually. Click to explore a detailed breakdown of our findings in Brockhaus Technologies' earnings growth report. Insights from our recent valuation report point to the potential undervaluation of Brockhaus Technologies shares in the market. XTRA:BKHT Ownership Breakdown as at Jul 2024 Hypoport Simply Wall St Growth Rating: ★★★★☆☆ Overview: Hypoport SE is a technology-based financial service provider in Germany with a market capitalization of approximately €2.07 billion. Operations: The company generates revenue primarily through its Credit Platform and Insurance Platform, with €155.60 million and €66.29 million respectively. Insider Ownership: 35.1% Earnings Growth Forecast: 31.9% p.a. Hypoport SE, a German growth company with significant insider ownership, reported a strong increase in Q1 earnings for 2024, with sales rising to €107.47 million from €93.72 million and net income increasing to €3.04 million from €0.503 million year-over-year. Despite these gains, its forecasted annual revenue growth of 13.4% lags behind the high-growth benchmark of 20%, though it still surpasses the German market average of 5.4%. The company's earnings are expected to grow by 31.9% annually over the next three years, outpacing the market projection of 18.9%. However, its return on equity is projected to remain low at around 9.1% in three years' time. Click here to discover the nuances of Hypoport with our detailed analytical future growth report. According our valuation report, there's an indication that Hypoport's share price might be on the expensive side. XTRA:HYQ Earnings and Revenue Growth as at Jul 2024 Redcare Pharmacy Simply Wall St Growth Rating: ★★★★☆☆ Overview: Redcare Pharmacy NV is an online pharmacy operating across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market capitalization of €2.85 billion. Operations: The company generates €1.62 billion from its DACH segment and €0.37 billion internationally. Insider Ownership: 17.7% Earnings Growth Forecast: 47.4% p.a. Redcare Pharmacy, a German growth company with high insider ownership, reported increased Q1 2024 sales of €560.22 million, up from €372.05 million year-over-year, and a reduced net loss of €7.81 million. Despite its highly volatile share price recently, the company is trading at 71.8% below its estimated fair value and is forecasted to become profitable within three years with an expected annual profit growth above the market average. However, its projected revenue growth rate of 17.1% per year is modest compared to some high-growth benchmarks but still exceeds the German market's average of 5.4%. The forecasted return on equity remains low at 7.5%. Click here and access our complete growth analysis report to understand the dynamics of Redcare Pharmacy. In light of our recent valuation report, it seems possible that Redcare Pharmacy is trading beyond its estimated value. XTRA:RDC Ownership Breakdown as at Jul 2024 Key Takeaways Click here to access our complete index of 17 Fast Growing German Companies With High Insider Ownership. Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world. Seeking Other Investments? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include XTRA:BKHT XTRA:HYQ and XTRA:RDC. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]
Three German Exchange Growth Companies With High Insider Ownership And At Least 31% Earnings Growth
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...